IL1B and metabolic syndrome: Thus, the present study reveals that many of the beneficial effects of elevated tissue n-3 PUFA status on inflammation and metabolic syndrome are dependent on the modulation of the gut microbiota, but that the lowering effects of n-3 PUFA on IL-1β and plasma TG appear to be gut microbiota-independent.